Sharyl Attkisson - December 29, 2022 at 02:22PM
BioNTech doses first patient in herpes vaccine study
Click on the headline to get the full report at Sharyl Attkisson
The following is an excerpt from Reuters. BioNtech has dosed the first patient with its BNT163 herpes vaccine candidate designed to prevent genital lesions as part of a first-in-human Phase 1 clinical research study, the German vaccine maker said on Wednesday. The vaccine candidate is meant to prevent HSV-2, the herpes simplex virus that causes […]
Sharyl Attkisson - December 29, 2022 at 02:22PM BioNTech doses first patient in herpes vaccine study Click on the headline to get the full report at Sharyl Attkisson
0 Comments
Leave a Reply. |
Just the News JusttheNews.com is committed to just reporting facts from journalists with a long record of public trust and excellence. In an era where opinion and supposition are too often substituted for fact and where journalists rush to get things first and hope their stories are correct, JusttheNews.com tries to stand out by returning to the bedrock promise of getting news first, but first getting it right. We try to deliver exclusive news you can trust. Archives
January 2024
Categories |